ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Rogers Eyes Saccharin Ban

March 18, 1977

In Brief: Carbone To Leave NCI for Wisconsin ACS’ Holleb Says Tobacco Industry Tries to Hide Ad Warning

October 3, 1975

Avastin Loses Indication for Breast Cancer

November 18, 2011

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

April 22, 1994

DCPC Board Finally Approves Prescribe for Health Concept on 7-4 Vote, Okays RFA On Micronutrients

October 21, 1988

In Brief: NCI Contract Plans Shaping Up As RFP “Season” Approaches; L-B Profit Told

September 13, 1974